Editorial - (2021) Volume 10, Issue 1
Received: 18-Jan-2021 Published: 26-Jan-2021
The recently published DBMR report in the Drug Discovery Market entitled Artificial Intelligence (AI) is a detailed analogy that offers the reader a hand to companies to succeed in the market by providing them with a range of market insights and Artificial Intelligence (AI) in the drug discovery industry.
Artificial Intelligence (AI) has covered and evaluated the potential of the Worldwide Market Industry in Drug Discovery Market size and offers statistics and information on market trends, market forecasting, growth factors, main challenges, major drivers & constraints, opportunities and forecasts.
The Artificial Intelligence (AI) report in the Drug Discovery market report, which is proficient and detailed, highlights primary and secondary drivers, market share, leading segments, future sales volume, and geographical analysis. This market research report provides an in-depth study of the market structure and a forecast of the different market segments and sub-segments.
Microsoft, NVIDIA Corporation, IBM Corporation, Atomwise, Inc., DEEP GENOMICS, Cloud Pharmaceuticals, Inc., Insilico Medicine, BenevolentAI Ltd, Exscientia, Cyclica Inc., twoXAR, Incorporated, OWKIN, INC., XtalPi Inc., BERG LLC, among other domestic and global players, are the key players covered in the Artificial Intelligence (AI) market study for drug discovery.
Artificial intelligence (AI) in drug discovery market is segmented on the basis of offering, technology, drug type, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
In the drug discovery industry, artificial intelligence (AI) is segmented on the basis of offering, technology, type of drug, application and end user. The growth of these segments will help you evaluate weak industry growth segments and provide users with useful business overview and market insight to help them make strategic decisions to identify core market application applications.
In the drug discovery industry, artificial intelligence (AI) is segmented into software and services based on offerings. On the basis of technology, the drug discovery market for artificial intelligence (AI) is segmented into machine learning and other technologies. Machine learning is further categorized into deep learning, supervised learning and reinforcement learning.